Korean J Lab Med.  2003 Aug;23(4):229-233.

Bone Marrow Expression and Plasma Concentration of Basic Fibroblast Growth Factor in Patient with Idiopathic Thrombocytopenic Purpura

Affiliations
  • 1Department of Laboratory Medicine, Chungbuk University Medical School, Cheongju.
  • 2Department of Laboratory Medicine, Korea University Medical College, Seoul, Korea. labmd@korea.ac.kr

Abstract

BACKGROUND
Basic Fibroblast Growth Factor (bFGF) is known to be closely related to myelofibrosis and hematopoiesis including magakaryopoiesis. The main bone marrow finding in patients with idiopathic thrombocytopenic purpura (ITP) is an increased megakaryopoiesis without myelofibrosis. Purposes of this study are to evaluate the changes in bFGF expression pattern in the bone marrow of patients with ITP and to correlate them with the plasma concentrations of bFGF. METHODS: Paraffin-sections of bone marrow biopsies from 17 cases ITP and 7 cases normal controls, without pathological alterations, were investigated by immunohistochemistry for bFGF and CD68. The plasma levels of bFGF were evaluated by enzyme immunoassay in 7 cases of ITP and controls. RESULTS: The bFGF was strongly expressed in stromal cells and weakly in megakaryocytes in normal controls. The density of the bFGF-expressing stromal cells was decreased in 70% (12/17) of the patients with ITP, compared with none in the other controls. The number of stromal cells in patients with ITP was similar to those in the control groups. The bFGF plasma levels were significantly lower in almost all the ITP patients compared to the control group. CONCLUSIONS: The results indicate that concentrations of bFGF in plasma and bone marrow stromal cells of ITP were decreased. Although the mechanism of low cellular and plasma concentrations of bFGF needs to be elucidated, these findings may complement the serologic and morphological diagnosis of ITP.

Keyword

ITP; Idiopathic thrombocytopenic purpura; bFGF; basic fibroblast growth factor; megakaryopoiesis

MeSH Terms

Biopsy
Bone Marrow*
Complement System Proteins
Diagnosis
Fibroblast Growth Factor 2*
Hematopoiesis
Humans
Immunoenzyme Techniques
Immunohistochemistry
Megakaryocytes
Mesenchymal Stromal Cells
Plasma*
Primary Myelofibrosis
Purpura, Thrombocytopenic, Idiopathic*
Stromal Cells
Complement System Proteins
Fibroblast Growth Factor 2
Full Text Links
  • KJLM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr